Atrial fibrillation

NICE's guideline on atrial fibrillation, recommendation 1.2.2] Quality statement 2: Use of aspirin Quality statement Adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention. Rationale The risks of taking aspirin outweigh any benefits of taking it as monotherapy for stroke prevention in adults with atrial fibrillation. Healthcare professionals should be aware that adults with atrial fibrillation may need to take aspirin for other indications. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure Evidence of local monitoring arrangements to ensure that adults with atrial fibrillation are not prescribed aspirin as monotherapy for stroke prevention. Data source: Local data collection. Process Proportion of adults with atrial fibrillation who are prescribed aspirin as monotherapy for stroke prevention. Numerator – the number in the denominator who are prescribed aspirin as monotherapy for stroke prevention. Denominator – the number of adults with atrial fibrillation. Data source: Local data collection. Data can be collected using the Royal College of Physicians' Sentinel Stroke National Audit Programme (SSNAP), question 2.1.6. Outcome Rates of
